Olimel (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The amino‑acid blend in Olimel supplies the building blocks required for protein synthesis. Once infused, the amino acids are taken up by cells, activating the mTOR pathway and other translational mechanisms that promote muscle maintenance, tissue repair, and energy production, while also supporting nitrogen balance in the body.

The dose of Olimel is individualized. A qualified prescriber determines the amount, concentration, and infusion rate based on the patient’s weight, clinical condition, renal and hepatic function, and overall nutritional requirements. No fixed regimen is provided in public documents.

Safety data for Olimel in pregnancy and lactation are limited. Because it is a parenteral nutrition product, it should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To order Olimel, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and the necessary import documentation.

Olimel offers a comprehensive amino‑acid profile that includes both essential and non‑essential amino acids, similar to other high‑quality parenteral nutrition solutions. Compared with products that contain only essential amino acids, Olimel may provide broader metabolic support, but the choice depends on the patient’s specific clinical needs and physician preference.

Olimel must be stored at 2‑8 °C. Keep the solution refrigerated, protect it from light, and avoid freezing or shaking the container. Follow the manufacturer’s labeling for any additional handling instructions to maintain product stability.

Olimel is administered intravenously, typically through a central venous catheter or a peripheral line, depending on the prescribed concentration and infusion rate. The infusion is performed under aseptic conditions, and the rate is adjusted according to the patient’s metabolic needs and clinical monitoring.

Serious risks include severe allergic reactions such as anaphylaxis, significant electrolyte disturbances, acute renal or hepatic dysfunction, and hyperammonemia. Continuous monitoring of vital signs, renal function, liver enzymes, and electrolyte levels is essential to detect and manage these potential complications promptly.

Olimel should be avoided in patients with known hypersensitivity to any of its amino‑acid components, those with inborn errors of amino‑acid metabolism, and individuals in whom parenteral nutrition is contraindicated due to severe fluid overload or uncontrolled metabolic disorders.